placeholder image
A. Chiappori All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • Phase 2 trial of nivolumab and ramucirumab for relapsed mesothelioma: HCRN-LUN15-299. 
    JTO Clin Res Rep. 2023
  • Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC. 
    New England Journal of Medicine. 2018
  • Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer. 
    New England Journal of Medicine. 2017
    • Contact
    full name
  • A. Chiappori
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration